12 research outputs found

    Comparison of newtonian and fourier thermal analysis techniques for calculation of latent heat and solid fraction of aluminum alloys

    Get PDF
    The cooling curve analysis (CCA) has been used extensively in the metal casting industry, usually to predict alloy compositio n and microstructure constituents. The use of CCA can be expanded to other areas of solidification if the zero curves can be properly calculated. In this paper the Newtonian and Fourier techniques of zero curve determination are described. These techniques were developed to calculate latent heat and to determine the correlations between solid fraction and temperature/time for Al-7 wt%Si alloy. The importance of the changes in heat capacity and density of solid and liquid phases during solidification on the latent heat calculations was examined. The latent heat calculated by Computer-Aided Cooling Curve Analysis (CA-CCA) method is compared with those reported in the literature. The effect of experimental procedure and type of sampling cup on the latent heat calculations were studied for both techniques

    Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

    Get PDF
    Background Results of small trials indicate that fluoxetine might improve functional outcomes after stroke. The FOCUS trial aimed to provide a precise estimate of these effects. Methods FOCUS was a pragmatic, multicentre, parallel group, double-blind, randomised, placebo-controlled trial done at 103 hospitals in the UK. Patients were eligible if they were aged 18 years or older, had a clinical stroke diagnosis, were enrolled and randomly assigned between 2 days and 15 days after onset, and had focal neurological deficits. Patients were randomly allocated fluoxetine 20 mg or matching placebo orally once daily for 6 months via a web-based system by use of a minimisation algorithm. The primary outcome was functional status, measured with the modified Rankin Scale (mRS), at 6 months. Patients, carers, health-care staff, and the trial team were masked to treatment allocation. Functional status was assessed at 6 months and 12 months after randomisation. Patients were analysed according to their treatment allocation. This trial is registered with the ISRCTN registry, number ISRCTN83290762. Findings Between Sept 10, 2012, and March 31, 2017, 3127 patients were recruited. 1564 patients were allocated fluoxetine and 1563 allocated placebo. mRS data at 6 months were available for 1553 (99·3%) patients in each treatment group. The distribution across mRS categories at 6 months was similar in the fluoxetine and placebo groups (common odds ratio adjusted for minimisation variables 0·951 [95% CI 0·839–1·079]; p=0·439). Patients allocated fluoxetine were less likely than those allocated placebo to develop new depression by 6 months (210 [13·43%] patients vs 269 [17·21%]; difference 3·78% [95% CI 1·26–6·30]; p=0·0033), but they had more bone fractures (45 [2·88%] vs 23 [1·47%]; difference 1·41% [95% CI 0·38–2·43]; p=0·0070). There were no significant differences in any other event at 6 or 12 months. Interpretation Fluoxetine 20 mg given daily for 6 months after acute stroke does not seem to improve functional outcomes. Although the treatment reduced the occurrence of depression, it increased the frequency of bone fractures. These results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function. Funding UK Stroke Association and NIHR Health Technology Assessment Programme

    Recent temperature and precipitation increases in West Siberia and their association with the Arctic Oscillation

    No full text
    Surface air temperature and precipitation records for the years 1958-1999 from ten meteorological stations located throughout West Siberia are used to identify climatic trends and determine to what extent these trends are potentially attributable to the Arctic Oscillation (AO). Although recent changes in atmospheric variability are associated with broad Arctic climate change, West Siberia appears particularly susceptible to warming. Furthermore, unlike most of the Arctic, moisture transport in the region is highly variable. The records show that West Siberia is experiencing significant warming and notable increases in precipitation, likely driven, in part, by large-scale Arctic atmospheric variability. Because this region contains a large percentage of the world's peatlands and contributes a significant portion of the total terrestrial freshwater flux to the Arctic Ocean, these recent climatic trends may have globally significant repercussions. The most robust patterns found are strong and prevalent springtime warming, winter precipitation increases, and strong association of non-summer air temperatures with the AO. Warming rates for both spring (0.5-0.8 °C/decade) and annual (0.3-0.5°C/decade) records are statistically significant for nine often stations. On average, the AO is linearly congruent with 96% (winter), 19% (spring), 0% (summer), 67% (autumn) and 53% (annual) of the warming found in this study. Significant trends in precipitation occur most commonly during winter, when four of ten stations exhibit significant increases (4-13 %/decade). The AO may play a lesser role in precipitation variability and is linearly congruent with only 17% (winter), 13% (spring), 12% (summer), 1% (autumn) and 26% (annual) of precipitation trends

    Feasibility of reporting results of large randomised controlled trials to participants:experience from the Fluoxetine or Control under supervision (FOCUS) trial

    No full text
    Objectives Informing research participants of the results of studies in which they took part is viewed as an ethical imperative. However, there is little guidance in the literature about how to do this. The Fluoxetine Or Control Under Supervision trial randomised 3127 patients with a recent acute stroke to 6 months of fluoxetine or placebo and was published in the Lancet on 5 December 2018. The trial team decided to inform the participants of the results at exactly the same time as the Lancet publication, and also whether they had been allocated fluoxetine or placebo. In this report, we describe how we informed participants of the results.Design In the 6-month and 12-month follow-up questionnaires, we invited participants to provide an email address if they wished to be informed of the results of the trial. We re-opened our trial telephone helpline between 5 December 2018 and 31 March 2019.Setting UK stroke services.Participants 3127 participants were randomised. 2847 returned 6-month follow-up forms and 2703 returned 12-month follow-up forms; the remaining participants had died (380), withdrawn consent or did not respond.Results Of those returning follow-up questionnaires, a total of 1845 email addresses were provided and a further 50 people requested results to be sent by post. Results were sent to all email and postal addresses provided; 309 emails were returned unrecognised. Seventeen people replied, of whom three called the helpline and the rest responded by email.Conclusion It is feasible to disseminate results of large trials to research participants, though only around 60% of those randomised wanted to receive the results. The system we developed was efficient and required very little resource, and could be replicated by trialists in the future.Trial registration number ISRCTN83290762; Post-results

    Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis

    No full text

    Search for intermediate-mass black hole binaries in the third observing run of Advanced LIGO and Advanced Virgo

    No full text
    International audienceIntermediate-mass black holes (IMBHs) span the approximate mass range 100−105 M⊙, between black holes (BHs) that formed by stellar collapse and the supermassive BHs at the centers of galaxies. Mergers of IMBH binaries are the most energetic gravitational-wave sources accessible by the terrestrial detector network. Searches of the first two observing runs of Advanced LIGO and Advanced Virgo did not yield any significant IMBH binary signals. In the third observing run (O3), the increased network sensitivity enabled the detection of GW190521, a signal consistent with a binary merger of mass ∼150 M⊙ providing direct evidence of IMBH formation. Here, we report on a dedicated search of O3 data for further IMBH binary mergers, combining both modeled (matched filter) and model-independent search methods. We find some marginal candidates, but none are sufficiently significant to indicate detection of further IMBH mergers. We quantify the sensitivity of the individual search methods and of the combined search using a suite of IMBH binary signals obtained via numerical relativity, including the effects of spins misaligned with the binary orbital axis, and present the resulting upper limits on astrophysical merger rates. Our most stringent limit is for equal mass and aligned spin BH binary of total mass 200 M⊙ and effective aligned spin 0.8 at 0.056 Gpc−3 yr−1 (90% confidence), a factor of 3.5 more constraining than previous LIGO-Virgo limits. We also update the estimated rate of mergers similar to GW190521 to 0.08 Gpc−3 yr−1.Key words: gravitational waves / stars: black holes / black hole physicsCorresponding author: W. Del Pozzo, e-mail: [email protected]† Deceased, August 2020

    Open data from the first and second observing runs of Advanced LIGO and Advanced Virgo

    Get PDF
    Advanced LIGO and Advanced Virgo are monitoring the sky and collecting gravitational-wave strain data with sufficient sensitivity to detect signals routinely. In this paper we describe the data recorded by these instruments during their first and second observing runs. The main data products are gravitational-wave strain time series sampled at 16384 Hz. The datasets that include this strain measurement can be freely accessed through the Gravitational Wave Open Science Center at http://gw-openscience.org, together with data-quality information essential for the analysis of LIGO and Virgo data, documentation, tutorials, and supporting software

    31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

    No full text
    corecore